The Future of Real-World Evidence: U.S. Market Insights and Projections to 2033
The U.S. Real World Evidence Solutions Market Size is Anticipated to Exceed USD 20.32 Billion by 2033, Growing at a CAGR of 12.37% from 2023 to 2033. As per the U.S. FDA definition, real-world evidence (RWE) is clinical evidence that could be derived from the analysis of real-world data (RWD) about the potential benefits and usage of medical products.